Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
alt text

Marketed pharmaceutical medicines constantly evolve throughout their lifecycles – new indications, improved formulations or packaging, updated manufacturing methods, validity period extensions, labeling updates and more.

With increasing global regulatory requirements, maintaining compliance of the products in your portfolio is essential to your right-to-operate.

Detailed planning and proper tracking of lifecycle management (LCM) across all relevant geographies are key to ensuring the full value of your products, helping you to avoid duplicative activities, reduce non-compliance risks and efficiently manage your regulatory expertise.

In this webinar, participants will build a better understanding of:

    Product lifecycle strategies and key corresponding regulatory strategies

    Effective global LCM planning including developing and maintaining timelines to optimize product extensions
    Benefits and payback of appropriate LCM tracking tools
    The importance of CMC regulatory compliance in the context of LCM, especially manufacturing site changes
    Lifecycle management for divestments and acquisitions

Please join us to learn more about how to optimize your products and portfolio -- across the entire span of their regulatory life – to unleash full product value.


Speaker:

alt text

Christina Bodurow, Ph.D.

Vice President, Global Regulatory Affairs

IQVIA


Dr. Christina (Chris) Bodurow received her Bachelors in Science from Kalamazoo College, and her Ph.D. in Organic Chemistry from Princeton University. Chris is currently Vice-President, Global Regulatory Affairs, in the Data Sciences, Safety and Regulatory Division at IQVIA. Chris’ prior experience includes 33 years at Eli Lilly and Company. She held responsibilities including Senior Director of External Sourcing in the Medicines Development Unit (MDU), Chief Operating Officer (COO), Product Research & Development (CMC component of LRL), as well as global R&D Operations Leader for the Prozac and Xigris Product Teams. Chris Bodurow has served in a number of professional and community volunteer roles, including on the Board of Directors of the American Chemical Society, the Chemistry Advisory Board for Princeton Chemistry, the Board of Directors of the Indianapolis Symphony Orchestra and the Kalamazoo College Board of Trustees.


Hosted by

Maire Gerrard

Custom Content Writer

Informa Pharma Intelligence

Complete the form to register for our webinar!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio

By completing this form you agree IQVIA and Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest. This is subject to IQVIA’s privacy policy and Pharma Intelligence UK Ltd’s privacy policy.